[New information about fumaric acid esters (Fumaderm): results of a workshop of experts].
Standard
[New information about fumaric acid esters (Fumaderm): results of a workshop of experts]. / Mrowietz, Ulrich; Adamczyk, A; Augustin, Matthias; Boehncke, W H; Bonnekoh, B; Gambichler, T; Hengge, U; Lippert, U; Ludwig, R J; Luger, T; Merk, H F; Norgauer, J; Philipp, S; Reich, K; Röcken, M; Rostami-Yazdi, M; Schön, M P; Scola, N; Sticherling, M; Thaci, D; Viehweg, A; Wallbrecht, K; Wozel, G; Zouboulis, C C; Neureither, M.
In: J DTSCH DERMATOL GES, Vol. 9 Suppl 4, 2011, p. 1-13.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - [New information about fumaric acid esters (Fumaderm): results of a workshop of experts].
AU - Mrowietz, Ulrich
AU - Adamczyk, A
AU - Augustin, Matthias
AU - Boehncke, W H
AU - Bonnekoh, B
AU - Gambichler, T
AU - Hengge, U
AU - Lippert, U
AU - Ludwig, R J
AU - Luger, T
AU - Merk, H F
AU - Norgauer, J
AU - Philipp, S
AU - Reich, K
AU - Röcken, M
AU - Rostami-Yazdi, M
AU - Schön, M P
AU - Scola, N
AU - Sticherling, M
AU - Thaci, D
AU - Viehweg, A
AU - Wallbrecht, K
AU - Wozel, G
AU - Zouboulis, C C
AU - Neureither, M
PY - 2011
Y1 - 2011
KW - Comorbidity
KW - Humans
KW - Quality of Life
KW - Prospective Studies
KW - Registries
KW - Follow-Up Studies
KW - Clinical Trials as Topic
KW - Pilot Projects
KW - Drug Administration Schedule
KW - Dose-Response Relationship, Drug
KW - Administration, Oral
KW - Sick Role
KW - Biological Availability
KW - Education
KW - Alopecia Areata/drug therapy/epidemiology/psychology
KW - Autoimmune Diseases/drug therapy/epidemiology/psychology
KW - Dermatologic Agents/administration & dosage/adverse effects/pharmacokinetics
KW - Fumarates/administration & dosage/adverse effects/pharmacokinetics
KW - Immunoglobulin G/administration & dosage/adverse effects
KW - Metabolic Clearance Rate/physiology
KW - PUVA Therapy/methods
KW - Psoriasis/drug therapy/epidemiology/psychology
KW - Receptors, Tumor Necrosis Factor/administration & dosage
KW - Comorbidity
KW - Humans
KW - Quality of Life
KW - Prospective Studies
KW - Registries
KW - Follow-Up Studies
KW - Clinical Trials as Topic
KW - Pilot Projects
KW - Drug Administration Schedule
KW - Dose-Response Relationship, Drug
KW - Administration, Oral
KW - Sick Role
KW - Biological Availability
KW - Education
KW - Alopecia Areata/drug therapy/epidemiology/psychology
KW - Autoimmune Diseases/drug therapy/epidemiology/psychology
KW - Dermatologic Agents/administration & dosage/adverse effects/pharmacokinetics
KW - Fumarates/administration & dosage/adverse effects/pharmacokinetics
KW - Immunoglobulin G/administration & dosage/adverse effects
KW - Metabolic Clearance Rate/physiology
KW - PUVA Therapy/methods
KW - Psoriasis/drug therapy/epidemiology/psychology
KW - Receptors, Tumor Necrosis Factor/administration & dosage
M3 - SCORING: Zeitschriftenaufsatz
VL - 9 Suppl 4
SP - 1
EP - 13
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
ER -